Luisella Righi

5.5k total citations
134 papers, 3.5k citations indexed

About

Luisella Righi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Luisella Righi has authored 134 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 67 papers in Oncology and 27 papers in Epidemiology. Recurrent topics in Luisella Righi's work include Lung Cancer Treatments and Mutations (46 papers), Lung Cancer Research Studies (35 papers) and Occupational and environmental lung diseases (25 papers). Luisella Righi is often cited by papers focused on Lung Cancer Treatments and Mutations (46 papers), Lung Cancer Research Studies (35 papers) and Occupational and environmental lung diseases (25 papers). Luisella Righi collaborates with scholars based in Italy, United States and France. Luisella Righi's co-authors include Mauro Papotti, Marco Volante, Giorgio V. Scagliotti, Anna Sapino, Mauro Papotti, Giuseppe Pelosi, Silvia Novello, Paola Cassoni, Gianni Bussolati and Ida Rapa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Luisella Righi

131 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luisella Righi Italy	35	1.9k	1.5k	1.2k	648	582	134	3.5k
Lodewijk A.A. Brosens Netherlands	30	2.0k 1.0×	1.1k 0.8×	991 0.8×	438 0.7×	601 1.0×	158	3.9k
Neda Kalhor United States	32	1.9k 1.0×	1.9k 1.3×	329 0.3×	403 0.6×	1000 1.7×	118	4.1k
Massimo Milione Italy	36	2.3k 1.2×	537 0.4×	2.0k 1.7×	1.1k 1.7×	685 1.2×	185	4.4k
Motoki Yano Japan	34	1.2k 0.6×	2.0k 1.4×	403 0.3×	756 1.2×	1.1k 2.0×	170	3.7k
Thomas Knösel Germany	38	1.6k 0.8×	1.2k 0.8×	398 0.3×	216 0.3×	1.5k 2.6×	176	4.3k
Roeland F. de Wilde Netherlands	23	2.4k 1.3×	354 0.2×	1.6k 1.3×	912 1.4×	1.2k 2.1×	63	3.8k
Arun Rajan United States	34	1.7k 0.9×	889 0.6×	413 0.3×	1.2k 1.8×	1.0k 1.7×	136	3.8k
Makoto Sonobe Japan	36	1.5k 0.8×	2.8k 1.9×	368 0.3×	1.0k 1.6×	780 1.3×	224	4.8k
Jean‐Christophe Sabourin France	31	2.5k 1.3×	1.0k 0.7×	428 0.4×	288 0.4×	845 1.5×	126	4.2k
Roberta Bertorelle Italy	27	771 0.4×	677 0.5×	440 0.4×	209 0.3×	810 1.4×	93	2.8k

Countries citing papers authored by Luisella Righi

Since Specialization

Citations

This map shows the geographic impact of Luisella Righi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisella Righi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisella Righi more than expected).

Fields of papers citing papers by Luisella Righi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisella Righi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisella Righi. The network helps show where Luisella Righi may publish in the future.

Co-authorship network of co-authors of Luisella Righi

This figure shows the co-authorship network connecting the top 25 collaborators of Luisella Righi. A scholar is included among the top collaborators of Luisella Righi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisella Righi. Luisella Righi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Remón, Jordi, Paolo Bironzo, Nicolas Girard, et al.. (2025). Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial. The Lancet Oncology. 26(9). 1215–1226. 1 indexed citations

Capelletto, Enrica, Fabrizio Tabbò, Francesco Leo, et al.. (2025). Therapeutic management of patients with advanced thymic malignancies: A review for clinicians. Lung Cancer. 204. 108554–108554.

Alborelli, Ilaria, Melanie Demes, Peter J. Wild, et al.. (2025). ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. SHILAP Revista de lepidopterología. 6(3). 19–19.

Balbi, Maurizio, Anna Caroli, Paolo Bironzo, et al.. (2024). CT-Guided Core Needle Biopsy of Pulmonary Lesions Associated With Cystic Airspaces: A Case-Control Study. American Journal of Roentgenology. 223(1). e2431042–e2431042. 3 indexed citations

Cerbone, Linda, Sara Delfanti, Paola Barbieri, et al.. (2024). Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases. PubMed. 14(1). 2424133–2424133. 1 indexed citations

Rossi, Giulio, Luisella Righi, Francesca Barbisan, et al.. (2024). BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. Journal of Personalized Medicine. 14(4). 394–394. 1 indexed citations

Righi, Luisella, et al.. (2023). Updates on lung neuroendocrine neoplasm classification. Histopathology. 84(1). 67–85. 13 indexed citations

Salaroglio, Iris C., Fabrizio Tabbò, Sofia La Vecchia, et al.. (2023). Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer. Clinical Cancer Research. 29(19). 3958–3973. 17 indexed citations

Bironzo, Paolo, Luca Primo, Silvia Novello, et al.. (2022). Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response. Clinical Lung Cancer. 23(6). e347–e352. 7 indexed citations

10.

Napoli, Francesca, Ida Rapa, Roberta Libener, et al.. (2022). Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(2). 233–244. 2 indexed citations

11.

Marino, Federica Zito, Greta Alì, Francesco Facchinetti, et al.. (2021). Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy. Expert Review of Anticancer Therapy. 21(8). 887–900. 7 indexed citations

12.

Napoli, Francesca, Angela Listì, Vanessa Zambelli, et al.. (2021). Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma. Cancers. 13(11). 2564–2564. 16 indexed citations

13.

Bironzo, Paolo, Maria Lucia Reale, Fabrizio Tabbò, et al.. (2021). Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. Cancers. 13(10). 2425–2425. 9 indexed citations

14.

D’Anna, Silvestro Ennio, Mauro Maniscalco, Vitina Carriero, et al.. (2020). Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients. Journal of Clinical Medicine. 9(6). 1807–1807. 6 indexed citations

15.

Gesmundo, Iacopo, Valentina Audrito, Nicoletta Vitale, et al.. (2019). Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Proceedings of the National Academy of Sciences. 116(6). 2226–2231. 28 indexed citations

16.

Riganti, Chiara, Iris C. Salaroglio, Chiara Falcomatà, et al.. (2017). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. OncoImmunology. 7(3). e1398874–e1398874. 34 indexed citations

17.

Rindi, Guido, Catherine Klersy, Frediano Inzani, et al.. (2013). Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocrine Related Cancer. 21(1). 1–16. 146 indexed citations

18.

Righi, Luisella, et al.. (2012). Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 460(4). 415–421. 8 indexed citations

19.

Righi, Luisella, Mauro Papotti, Paolo Ceppi, et al.. (2010). Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy. Journal of Clinical Oncology. 28(9). 1534–1539. 126 indexed citations

20.

Faggiano, Antongiulio, Marco Volante, Ida Rapa, et al.. (2007). Somatostatin receptor immunohistochemistry in neuroendocrine tumors: a proposal of scoring system for clinical characterization and therapy selection. 14(1). 71–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact